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REDUCING POLYPHARMACY IN ELDERLY 
Abstract 
The fast growing in number of elderly in the population is what is causing an increase in the 
amount of medications prescribed for chronic diseases. Because the chronic disease requires 
adding medications to treat or stabilize them, the issue of polypharmacy start to emerge. Terrie Y. 
C. (2014), defines polypharmacy as, “The use of multiple medications by a patient. The number 
may vary, but generally ranges from 5 to 10.” The issue of polypharmacy is of particular concern 
in older people who, compared to younger individuals, tend to have more disease conditions for 
which therapies are prescribed. This paper is based on a successful completion of an Objective 
Structured Clinical Examination (OSCE) and oral defense. A case report was analyzed and the 
topic, “Preventing Polypharmacy in elderly,” was developed. This paper is going to examine this 
case report highlighting the use of more medications and how it affects elderly patients who are 
at a greater risk for adverse drug events due to metabolic changes and decreased drug clearance 
associated with aging and many drugs make it worse. An extensive literature review looking at 
the definition of polypharmacy, determining the extent and nature of polypharmacy in the 
elderly, and the effects associated with polypharmacy in general practice. Having a greater 
understanding that a greater numbers of medications are associated with negative health 
outcomes will help to further define the effects associated with unnecessary medication use in an 
elderly patient. Thereby fully evaluating all patient medications at each visit to prevent 
polypharmacy from occurring.  
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Background  
In our health care system today, polypharmacy among elderly has become a major 
concern. Elderly with comorbidities, taking multiple medications are at the greatest risk for 
potential adverse reactions from medications. If elderly patients are taking over-the-counter 
medications, herbs, and supplements without consulting their primary care provider, they stand 
at risk of adverse reactions associated with polypharmacy. In connection with the definition, 
polypharmacy may result from patients visiting multiple providers with prescribing privileges, 
pharmacies, and continuing to take medications already discontinued by their primary providers. 
There is a great need for providers to intervene in order to prevent polypharmacy in elderly, by 
reviewing medication on every visit, gather a through history and conduct a comprehensive 
system review and physical assessment. Providers should ask open-ended questions regarding all 
medications that the patient is on including the use of herbal or dietary supplements. In addition, 
the patient comprehensive patient review and assessment gives providers an opportunity to find 
out more about any possible adverse reactions patients may be experiencing that may be as a 
result of medications. Healthcare providers are at an exceptional position as they can detect and 
intervene early in case of any potentially unnecessary medications and associated adverse drug 
interactions. Whereas polypharmacy is defined as the use of multiple medications more 
commonly, more than five to ten, or use of more drugs than are not even clinically indicated and 
are unnecessary, the effects of polypharmacy on our elderly population is important. 
Polypharmacy is generally been found associated with poor medication adherence, drug-drug 
interactions, medication errors and adverse drug reactions which includes falls, hip fractures, 
confusion and delirium of which has increased the number of emergency room visits and 
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hospitalization when in essence, this can be prevented (Farrell, Shamji, Monahan, & Merkley,  
2013). 
The case study in this report involves an 87-year-old female who comes into the clinic for 
“Follow up after hospital discharge.” The patient was in the hospital for three days for UTI and 
fatigue, also feeling dizzy. History taking revealed, patient lives in ALF, Daughter visits 
regularly and sets her medications, and has a personal care assistant that checks on her daily. 
While assessing this patient, I realized that she has dementia and was forgetful with a small 
element of confusion. She has a history of diabetes, COPD, Anemia, Hypertension, depression 
and neuropathy. Patient is on twelve different kinds of medication. Today she is complaining of 
feeling dizzy especially in the morning upon awakening and her blood pressure is 88/40. I 
question an issue of medication compliance given the number of medication patient is on and 
comorbidity.  
The purpose of discussing this case in this paper is to alert clinicians the need for 
balancing between over and under-prescribing, especially when they have to prescribe multiple 
medications to manage clinically complex older adults. In this case, I will focus more on the 
number of medications and its effects, especially in elderly patients.  The case will be used as a 
model example of a typical elderly patient with chronic conditions and multiple medications, 
some unnecessary, to show clinicians that there is a need to match the complex needs of older 
patients with those of disease specific clinical practice guidelines when reviewing medication 
regimen. The case report will also create awareness to clinicians that, use of a more systemic 
approach to guide them in modifying medication regimens to the needs of the individual patient 
while matching medication regimen to the patient`s condition and goals of care are what is 
needed to prevent polypharmacy in the elderly population. By doing this, clinicians will need to 
6 
REDUCING POLYPHARMACY IN ELDERLY 
consider medications that should be discontinued or substituted in every visit as they conduct 
medication reviews for their patient with a major focus on elderly patients. Considering this case 
report, I also intend to remind clinicians that they need to reconsider while prescribing or 
reviewing medication with their patient, the appropriateness of medication late in life. If they 
have to prescribe late in life, they need to consider the patient`s remaining life expectancy and 
the goals of care, the need for existing medications and the appropriateness of making the new 
prescription decision for the patient. Although polypharmacy commonly refers to prescribed 
medications, considering the use of over the counter medications and herbal supplements when 
completing the assessment and reviews of medication, is crucial in efforts to prevent 
polypharmacy.   
Case Report 
Chief complaint: F/U after hospital discharge.  
History of Present illness: E. M is a pleasant 87-year-old Caucasian female who presents to the 
clinic after a recently discharged from the hospital after a 3 day of stay with UTI and fatigue. 
Patient today is reporting feeling dizzy and tiredness especially in the morning upon waking or 
with change of position from laying to sitting.  Patient is alert and oriented x3, with some 
forgetfulness due to dementia otherwise, has good cognition functions for evaluation. Denies any 
s/sx of UTI during this visit, still has 3 more doses of Nitrofurantoin ER 100 mg left.  Of note, 
patient `s BP today is 88/40, with a heart rate of 50. Patient is on Losartan 50 mg daily with 
metoprolol 50 mg twice a day. She denies shortness of breath, fevers or chills.  
Past Medical History 
Dementia, Diabetes, COPD, Anemia, Hypertension, Depression, and Neuropathy 
 
7 
REDUCING POLYPHARMACY IN ELDERLY 
Surgical Hx. Hysterectomy many years ago. Patient unable to provide specific dates 
Current medications 
Donepezil 5 mg PO daily 
Fluticasone proprionate and salmeterol 250/50 1 puff BID 
Losartan 50 mg PO daily 
Metoprolol 50 mg BID 
Gabapentin 300 mg TID 
Paroxetine 20 mg PO daily 
Quetiapine 200 mg PO BID 
Insulin glargine 30 units SQ qhs 
Nitrofurantoin ER 100 mg PO BID x 7 days (3 Days left) 
Multivitamin PO daily 
Iron sulfate 325 mg PO BID 
Allergies: NKA 
Immunizations 
Influenza 11/17/2014 
Family History/Personal/Social History:  
Patient has a family history of heart disease and HTN but is unable to tell who secondary to 
dementia. She lives in ALF, Daughter visits regularly and sets her medications, and has a PCA 
that checks on her daily. Never smoked, no alcohol or illicit drug use. 
REVIEW OF SYSTEMS 
Constitutional: Reports dizziness and fatigue, denies any syncopal episodes or lightheadedness. 
Denies any fever or chills, or any problem falling asleep.  
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Cardiovascular: Denies chest pain, angina or pleuritic pain. Denies any heart palpitations or 
irregularity in rhythm. No history of heart murmur.  
Respiratory: Reports mild SOB with activity, has hx. Of COPD and is on Fluticasone 
proprionate and salmeterol 250/50.  
GI: Denies any changes in appetite, any difficulty swallowing, or chewing. Denies indigestion or 
constipation, no nausea, vomiting or diarrhea, and no hemorrhoids. No c/o abdominal pain 
GU: Denies pain/burning sensation on urination, urgency, frequency, difficulty urinating or 
incontinence 
Musculoskeletal: Independent 
Integumentary: Frail skin, bruises easily 
All other systems unremarkable, unless noted in the HPI.  
PHYSICAL EXAMINATION 
VS:  BP 88/40, HR 50, Temp 98.6, RR 24, FSBS this morning 107 
General appearance: 87-year-old Caucasian female, alert and oriented x3, interactive, and 
seems to be in no distress. Patient appears to be her age, she is frail and forgetful due to dementia 
sitting in the chair in no distress stating that she feels much better today compared to when she 
was in the hospital.   
HEENT:  Head Normocephalic, atraumatic. Pupils equal and reactive to light. Wears glasses had 
a routine visit with the eye doctor last week no concerns.  Hearing patent although mildly HOH, 
no hearing aids, no swelling, nares patent bilaterally, No sinus tenderness.  
NECK AND THYROID: Supple, no JVD or lymphadenopathy. 
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CARDIOVERSCULAR: Regular Rate and Rhythm, distant S1S2 heard, no murmurs gallops, 
or rubs. Trace edema to bilateral lower extremities varicose veins to left extremities wearing 
compression stocking to bilateral lower extremities.   
RESPIRATORY:  Lung sounds clear to auscultation in all lung fields. No increased effort in 
breathing noted no wheezes, rhonchi, or rales.  
GI: BS + in all quadrants, no masses palpated, soft, non-tender, no distended, no 
hepatosplenomegaly. 
NEUROLOGIC EXAM: Alert and oriented x3, cooperative. Mood and affect appropriate to 
situation. Has good cognition functions for evaluation. 
SKIN: warm, dry with cool temperature to touch to feet and fingers. Well hydrated, 2 bruises to 
LUQ from insulin injection. 
ETREMITIES: trace dependent edema to bilateral lower extremities, pulses +2 bilaterally. No 
clubbing. 
BACK: Unremarkable 
Assessment 
1. Polypharmacy 
2. Infection 
3. Diabetes 
4. Medication-induced Hypotension 
5. Anemia 
6. Hypoglycemia 
7. Thyroid  
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Plan 
A plan was developed with the patient based on each diagnosis. In regard to her hypotension 
with dizziness especially in the morning, it was determined that due to dementia she will benefit 
more from home care services to help in medication management, it was also determined that 
this is medication induced Hypotension: metoprolol was decreased to 25 mg PO BID, will 
continue with Losartan 50 mg daily. Since there was a dose reduction or adjustment, she was 
educated on common medication side effects especially antihypertensive like metoprolol which 
included fatigue. She was instructed to continue observing safety when changing positions from 
lying to sitting due to the potential for orthostatic drug-induced hypotension, and staying 
hydrated. If symptoms worsen to return to clinic sooner, although will need to be seen again in 2-
3 weeks to re-evaluate.  
Review of medication was completed in efforts to reduce polypharmacy in this patient. For 
this visit provider and patient agreed that due to problems with hypotension, it was appropriate to 
try dose reduction of metoprolol and because she denied pain or any concern, she had been on a 
high dose of Gabapentin for a long time. It was determined appropriate to decrease metoprolol to 
25 mg BID, and decrease gabapentin to 100 mg TID. The effectiveness of this intervention will 
be reviewed again on the next visit.  
For the diagnoses of Anemia, CHF, hypotension, dizziness, lightheadedness, fatigue, 
diabetes, infection and polypharmacy, lab was ordered to check BMP, BNP, CBC, Iron panel, 
Thyroid studies and basic EKG for baseline. Results were normal. She will continue with current 
interventions and reevaluate in subsequent visits. Patient was agreeable to the plan discussed.  
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A Review of Literature 
To better manage the patient in this case study, medication review was completed, to help 
with the issue of Polypharmacy. A literature review was conducted to determine the best way to 
reduce polypharmacy in elderly. A search was conducted using the University of North Dakota 
Harley French Library website. A systematic search of the literature was conducted using the 
online database CINAHL, Medline, and PubMed. The research articles were generated by 
utilizing the search entry with the terms of polypharmacy, polypharmacy among the elderly, 
adverse drug reactions and polypharmacy, and consequences and polypharmacy. After receiving 
a few research articles, a new search was conducted replacing the term of polypharmacy with 
multiple medications. These searches generated limited research articles in regard to the topic of 
polypharmacy. To produce more research articles, the publication dates were modified, which 
resulted in hundreds of articles to review. Some of the generated research articles were article 
linkers, which were not available. Of the research articles that were generated, the research 
articles containing participants < 65 years of age were excluded from the review of literature 
(ROL). Research articles containing samples of > 65 years of age or older, male and female, 
prescribed medications, over-the-counter medications, complementary medications, adverse drug 
reactions, drug-to-drug interactions, and complications associated with polypharmacy were 
considered for the ROL. The articles in the ROL were chosen based on search criteria and 
interventions in which valuable methods can be implemented when assessing patients for adverse 
effects of polypharmacy with the goal of preventing polypharmacy in elderly patients. 
Effects of Polypharmacy 
Polypharmacy and medication regimen complexities are the factors most commonly 
associated with most hospital discharge destinations, especially in older adult patients. A great 
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number of the older population, often use multiple medications, and therefore, clinicians should 
be trying to help with medication review and taking or eliminating unnecessary medications that 
predispose them into other risks besides comorbidities.  According to a study by Wimmer et al. 
(2014), high medication regimen complexity was inversely associated with discharge directly to 
home, while polypharmacy was not associated with discharge destination. Polypharmacy by 
itself is an independent risk factor for adverse outcomes in elderly patients, including 
hospitalization, nursing home placement, hypoglycemia, falls, and fractures, malnutrition, 
pneumonia, and deaths. Older adults make up the largest number of people consuming 
prescription drugs. They also have decreased tolerance to the effects of medication which puts 
them at exaggerated effects of medication when compared to younger patients.  
Screening and Prevention of Polypharmacy 
Older people often experience multiple co-morbidities and are prescribed multiple 
medications for these conditions. This puts them at an increased risks of adverse drug events, 
drug-to-drug, and drug-to-disease interactions. The risks increase as their age increases and 
physiological changes take place which both, have great influence in pharmacodynamics and 
pharmacokinetics. According to Gallagher & O’Mahony (2008) there are various criteria that 
have been devised to identify potentially inappropriate medications (PIMs) in older people. 
These include the Beers`s criteria which has been in use for a long time to detect PIMs and the 
Screening Tool of Older Persons’ inappropriate Prescriptions (STOPP). When compared to the 
Beers’ criteria, adoption of STOPP has been found effective in identifying significantly more 
PIMs. Adopting STOPP in our practice especially when screening older patients will not only 
help in screening for PIMs but will be a practice method that can be used to identify adverse drug 
effects in older people which often present with non-specific symptoms like confusion, falls or 
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constipation. Although STOPP will not substitute our clinical assessment and judgment, it’s very 
important for clinicians to consider medications as possible causes of most symptoms in older 
patients. Therefore, in efforts to prevent polypharmacy, if this is born in clinicians` mind, 
avoidance of unnecessary and potentially harmful cascades like trying to treat extrapyramidal 
effects of neuroleptic medication in older patients by prescribing an anticholinergic medication 
would be avoided. Potentially inappropriate prescribing is very common in older patients who 
present in primary care clinics or in hospitals. Gallagher, et al. (2008), reveals that STOPP 
criteria, when applied, can identify at least one potentially inappropriate medications in older 
patients requiring admission to hospital. Identifying adverse effects of inappropriate prescribed 
medication is very important as this usually contribute to most hospitalization in at least 11.5% 
of patients when screened with STOPP criteria. STOPP Criteria has been a very effective tool in 
identifying patients at high risk of inappropriate prescribed medication. According to de Groot et 
al. (2014), use of STOPP/START in practice by clinicians as one of the assessment tool has 
shown an increased appropriateness in prescribing especially in the elderly in a clinical setting 
when administered appropriately.  
Efforts to manage polypharmacy is the primary role of practitioners who coordinate 
patient cares and it is a demanding exercise.  To accomplish this, focusing on interventions that 
aim at improving the implementation of guideline and recommendations for polypharmacy into 
the practice when individual patient barriers are considered is necessary (Jäger, Szecenyi, & 
Steinhauser, 2015). A larger number of elderly patients already have multiple chronic diseases 
for which they are medicated and; taking five or more medications is polypharmacy. If a patient 
falls into this category, he/she is at a higher risk of potentially avoidable and even potentially 
harmful adverse drug reactions. To better manage polypharmacy, a multidisciplinary effort and 
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coordination of multiple prescribers, putting into practice a profound pharmacological 
knowledge and close monitoring of patients is what is needed. According to Jäger, et al. (2015), 
these guidelines for preventing polypharmacy in adult and geriatric patients in primary care with 
a focus on medications process will help greatly in reducing polypharmacy in elderly patients.   
i. Structured medication counseling (SMC). Providers should give a SMC to 
patients who are on five medications or more and present with risk factors for 
medication problems at least once a year. This way a complete inventory of actual 
medications that patients take and assessment of medication compliance and 
possible medication-related problems are addressed. 
ii. Consequent use of medication list. All patients with at least five or more 
medications should always be encouraged to take with them a complete and 
updated list of medications patients are actually taking t their appointments. 
iii. Medication reviews to reduce potentially inappropriate medications (PIMs). A 
review of patient medications by providers during each visit has been proven as a 
tool that can provide both explicit and implicit data when trying to find patient 
compliance to medication. It is recommended that providers regularly review the 
medication regimen of their patients with identified polypharmacy using a 
checklist like “medication appropriateness index (MAI)” and or drug-to-avoid 
lists such as Beer`s in the process of preventing polypharmacy.  
Outcomes and effectiveness 
Fried, et al. (2014) in their study as part of trying to prevent the issue of polypharmacy, 
has defined polypharmacy in terms of the number of prescribed medications in elderly persons. 
While considering age and co-morbidity, reducing polypharmacy considering the number of 
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prescribed medications patients are taking is crucial. Adjusting patient’s medications and or 
taking away unnecessary medications will bring a better healthcare outcome thus reducing the 
many cases of falls, fall outcomes, fall risk factors, adverse drug events, hospitalization, 
mortality and measures of function and cognition. Clinicians need to be aware of polypharmacy, 
which is considered in terms of number of medication, and the adverse outcome in elderly 
patients in efforts to prevent polypharmacy in elderly population living in the community.  
Adverse drug reactions cause an increased number of morbidity and mortality, especially 
in elderly patients. Olivia, et al. (2009) while focusing on the effects leading to hospitalization of 
elderly patients, assessed the incidence of ADRs and its associated factors which lead to hospital 
admissions in the elderly population, especially those patients aged >/=65 years admitted to the 
hospital and the result was surprising. Most often ADRs are causes of hospital admission 
especially for elderly patients due to co-morbidity and presence of chronic diseases. Addressing 
polypharmacy by primary care providers in each patient`s visits will greatly reduce these 
hospitalizations which sometimes end up to be fatal. There is a great need for increased 
availability of information for the general public in regard to potential ADRs related to self-
medication, and for clinicians’ awareness of ADRs due to drug-drug interactions 
and polypharmacy to help in fighting polypharmacy especially in elderly population. 
According to Williams (2014), older adults are the largest consumers of prescription 
medications. It is predicted that as the number in age increase so to the number of medication 
increase. One out of 20 patients is at a high risk of developing a drug-to-drug interaction, with at 
least half of this interaction from non-prescription medication. Research has also shown that a 
major and an independent risk factor for adverse outcomes including hospitalization, nursing 
home placement hypoglycemia, falls with injuries or fractures, pneumonia, malnutrition and 
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even death in the elderly patients is polypharmacy. Elderly patients don’t tolerate well the effects 
of medications in general. The elderly stand at a greater risk for adverse drug events due to 
metabolic changes and decreased drug clearance associated with aging which, many medications 
make worse. Multiple medications in elderly also pose an increased potential for medication to 
medication interaction, and the possibility of “prescribing cascade” where an adverse drug event 
will be misinterpreted as a new medical condition and additional medication therapy is then 
prescribed to treat this medical condition. Multiple medications in elderly too, are the reason for 
many issues with medication compliance due to changes in vision or cognition in many elderly 
patients.  
Conclusion  
According to Planton, & Edlund (2010), Polypharmacy is a major concern in the care of 
older adults. There are multiple factors that contribute to this issue of polypharmacy, and an 
initial step in trying to reduce this problem is recognizing these factors. To further reduce the 
problem of polypharmacy in elderly, efforts to identify individuals at risk for multiple 
medications, whereas implementing specific strategies in practice, will enable clinicians to 
develop safe and evidence-based medication regimens that will minimize the risk of adverse 
drug reactions. Most important in managing older adults is not necessarily trying to find out how 
many medications they are taking and trying to reduce them, but finding the right medication at 
the right dosage and for the shortest possible duration on a case-by-case basis is more beneficial. 
This way clinicians will be much safer and effective in their practice and will improve the quality 
of life of their elderly patients. 
Optimizing therapy for any individual patient may not be as easy or straightforward 
encounter for most clinicians. This will always be dependent on patient needs and comorbidity. 
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What makes it harder is the amount of randomized controlled studies that most often involve a 
single drug without always taking into consideration the confounding effects of various 
comorbidities and patient preferences. The manner in which clinicians approach prescribing for 
the younger patient does not always apply well in frail elderly patients who, have several 
comorbidities such as hypertension, depression, diabetes, myocardial infarction, and even 
osteoporosis which leads to polypharmacy. To prevent polypharmacy, clinicians need to try an 
“evidence of a modest reduction in the relative risk of disease-specific outcomes that are 
associated with individual medications and sometimes a combination of medication” (Kaur, et al. 
2009).    
An interdisciplinary approach, which would include nurses, physicians, pharmacists, and 
patients, is needed to effectively manage and reduce polypharmacy and its adverse reactions 
among the elderly. Although current nursing research material regarding polypharmacy are 
limited indicated a gap in the number of studies conducted regarding this issue. From the studies 
reviewed, the results demonstrate that the increasingly health related issue of polypharmacy 
among the elderly requires the immediate attention of health care professionals who can be 
pivotal in helping older patients manage their medications while trying to prevent polypharmacy. 
The best approach to reducing polypharmacy would include; giving clear information to their 
patient. They need to discuss with patients during visits the need to keep accurate list of all 
medications, including generic and brand names, dosages, frequency, and why they are taking 
medication. Patients should be informed that it is important to keep a complete list of providers 
they see, and local pharmacies they use. Providers also need to instruct and teach patients about 
each medication, including names, appearance, purpose and effects, side effects, potential 
adverse effects and interaction of each medication, importance of contacting the healthcare 
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provider with concerns or questions, potential drug-related problems that warrant emergency 
care, importance of taking medications exactly as directed, and importance of using only one 
pharmacy to obtain drugs. Encouraging organization is helpful too in improving compliance. In 
order to help patients better manage their medications, they should be warned against medication 
sharing, storing medications in a secure, dry location away from sunlight, refrigerating 
medications if necessary, disposing of old medications properly, and if appropriate, helping 
patients establish memory aids. This is especially important for geriatric patients with memory 
concerns. Advising them to link medication administration to their daily routine or to use color-
coded charts, automatic dispensers with bells, or voice-activated message services to remember 
to take their doses will help in doubling medication and in the long run avoid drug-to-drug 
interactions (Gallagher, et al. 2008).   
Learning Points.  
 
Complex medication regimens and polypharmacy need to be regularly checked because 
of possible interactions, side effects, inappropriate dependence, and treatment adherence 
problems. Inappropriate medication prescriptions, as well as drug abuse, should be avoided, at 
the same time medication omission also can be a problem. Therefore, careful considerations of 
the following geriatric pharmacology principles should always be born in the prescriber’s mind.  
 For some medication starting slow and going slow is crucial. The central nervous 
system is a particularly vulnerable drug target in the elderly.  
  Expect the unexpected like the side effects and drug interactions. Confusion is 
often the presenting symptom caused by almost any of the commonly used drugs. 
Other common manifestations are constipation, postural hypotension and falls. 
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The elderly is more prone to tendon damage with the use of quinolones and GI 
bleeding with NSAIDs.  
 Dynamic monitoring is necessary. Medications or dosages may need to be 
adjusted with changes in weight, renal function, or recurrent illness. Renal 
functions normally deteriorate with age, but there is large variability among 
different individuals. For example, when using medications like digoxin and 
lithium.  
 Avoid polypharmacy where possible as it may lead to side effects. Some common 
medications should be used if only the alternative is missing, including 
medications like codeine-containing analgesics. More often considering the 
possibility of drug-drug and drug-disease interactions prior to adding any new 
medications ought to be considered. For example, medications like NSAIDs can 
precipitate acute renal failure when used in patients with chronic renal diseases or 
can exacerbate high blood pressure in hypertensive patients.  
 Clinician needs to remember to give patients that present with a problem of 
polypharmacy a structured medication counseling at least once a year. In the 
process, clinicians need to complete an inventory of the actually taken 
medications and assess patients for adherence and any possible problems (Jäger, 
et al., 2015). 
 Clinicians need to ensure that their patient have along with them a list of 
consequent use of medication and if they don’t should provide one that has a 
complete and updated list of medications they are on (Jäger, et al., 2015). 
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 Clinicians need to regularly review medication regimens to reduce polypharmacy 
and reducing potentially inappropriate medications using tools such as 
“medication appropriateness index (MAI)”, and or drug to- avoid lists such as 
“PRISCUS-list” similar to the beers criteria (Jäger, et al., 2015).  
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